109 related articles for article (PubMed ID: 8672727)
1. Cytoxicity of [(5,6-dichloro-9a-n-propyl-2,3,9,9a-tetrahydro-3-oxo-1H fluoren-7-yl)oxy]acetic acid, an agent known to reduce brain edema.
Hall IH; Wyrick SD
Biomed Pharmacother; 1996; 50(1):19-23. PubMed ID: 8672727
[TBL] [Abstract][Full Text] [Related]
2. Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analogues.
Cragoe EJ; Woltersdorf OW; Gould NP; Pietruszkiewicz AM; Ziegler C; Sakurai Y; Stokker GE; Anderson PS; Bourke RS; Kimelberg HK
J Med Chem; 1986 May; 29(5):825-41. PubMed ID: 3701792
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective disposition and protein binding of [(5,6-dichloro-9a-propyl-3-oxo-2,3,9,9a-tetrahydro-1-H-fluoren-7 -yl)-oxy] acetic acid, a new cerebral antiedemic agent, in rats.
Lin JH; Hsieh JY
Drug Metab Dispos; 1988; 16(4):540-5. PubMed ID: 2903020
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxicity of [(N-alkyl-1,3-dioxo-1H,3H-isoindolin-5-yl)oxy]-alkanoic acids in murine and human tissue cultured cell lines.
Hall IH; Wyrick SD
Anticancer Res; 1995; 15(4):1365-9. PubMed ID: 7654022
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.
Hall IH; Wong OT; Chi LK; Chen SY
Anticancer Res; 1994; 14(5A):2053-8. PubMed ID: 7847849
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of [(N-alkyl-1H,3H-1-oxoisoindoline-5-yl-oxyl alkanoates and related benzamides in murine and human tissue cultured cell lines.
Hall IH; Wyrick SD; Waller CL
Anticancer Res; 1995; 15(4):1359-64. PubMed ID: 7654021
[TBL] [Abstract][Full Text] [Related]
7. The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides.
West DX; Liberta AE; Rajendran KG; Hall IH
Anticancer Drugs; 1993 Apr; 4(2):241-9. PubMed ID: 8098234
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of imides-N-alkyl semicarbazones, thiosemicarbazones, acetylhydrazones and related derivatives.
Hall IH; Wong OT; Chapman JM
Anticancer Drugs; 1995 Feb; 6(1):147-53. PubMed ID: 7756677
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells.
Izydore RA; Zhang Y; Zhou X; Warren AE; Wheaton JR; Hall IH
Anticancer Res; 2001; 21(1A):157-65. PubMed ID: 11299729
[TBL] [Abstract][Full Text] [Related]
10. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Inaba M; Fukui M; Yoshida N; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Mar; 42(3):1103-6. PubMed ID: 6277474
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.
Hall IH; Hall ES; Chi LK; Shaw BR; Sood A; Spielvogel BF
Anticancer Res; 1992; 12(4):1091-7. PubMed ID: 1503401
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepines.
Hall IH; Wong OT; Chi LK
Anticancer Drugs; 1993 Dec; 4(6):665-70. PubMed ID: 8298166
[TBL] [Abstract][Full Text] [Related]
13. The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
Hall IH; Lee KH
Anticancer Res; 1991; 11(1):337-42. PubMed ID: 2018369
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells.
Burnham BS; Gupton JT; Krumpe K; Webb T; Shuford J; Bowers B; Warren AE; Barnes C; Hall IH
Arch Pharm (Weinheim); 1998 Nov; 331(11):337-41. PubMed ID: 9881055
[TBL] [Abstract][Full Text] [Related]
15. The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells.
Hall IH; Izydore R; Hall ES; Miller MC; Daniels DL; Debnath ML; Woodard T
Anticancer Drugs; 1992 Jun; 3(3):273-80. PubMed ID: 1525409
[TBL] [Abstract][Full Text] [Related]
16. The cytotoxicity of 3-imino-1-oxoisoindolines in murine and human tissue culture cells.
Hall IH; Wong OT
Anticancer Drugs; 1994 Apr; 5(2):207-12. PubMed ID: 8049504
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine.
Hall IH; Peaty NJ; Henry JR; Easmon J; Heinisch G; Pürstinger G
Arch Pharm (Weinheim); 1999 Apr; 332(4):115-23. PubMed ID: 10327884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of 5-deaza-5,6,7,8-tetrahydrofolic acid and its N10-substituted analogues.
Taylor EC; Hamby JM; Shih C; Grindey GB; Rinzel SM; Beardsley GP; Moran RG
J Med Chem; 1989 Jul; 32(7):1517-22. PubMed ID: 2738886
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and anti-neoplastic activity of N2-isobutyryl-2'-deoxyguanosine-N7-cyanoborane derivatives.
Sood A; Shaw BR; Spielvogel BF; Hall ES; Chi LK; Hall IH
Pharmazie; 1992 Nov; 47(11):833-8. PubMed ID: 1492112
[TBL] [Abstract][Full Text] [Related]
20. The cytotoxicity of symmetrical and unsymmetrical bis(thiosemicarbazones) and their metal complexes in murine and human tumor cells.
Hall IH; Lackey CB; Kistler TD; Ives JS; Beraldo H; Ackerman LJ; West DX
Arch Pharm (Weinheim); 2000 Jul; 333(7):217-25. PubMed ID: 10965596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
